OA
CDMO icon

Operose Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Operose Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$22.8K – 658
2024
Q3 		$22.8K Hold
2,000
– – 0.01% 381
2024
Q2 		$14.3K Hold
2,000
– – 0.01% 397
2024
Q1 		$13.4K Hold
2,000
– – ﹤0.01% 445
2023
Q4 		$13K Buy
2,000
+1,225
+158% +$7.89K 0.01% 425
2023
Q3 		$7.32K Buy
+775
New +$9.33K ﹤0.01% 620

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Operose Advisors's CDMO Position: Q4 2024 in Review

Operose Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 2,000 shares — an estimated $22.8K sold.

Operose Advisors first reported a position in CDMO in Q3 2023 and held it in 5 quarters. The position peaked at $22.8K in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Operose Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 2,000 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $22.8K.
  • Operose Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2023 and held it in 5 quarters.
  • Operose Advisors's Avid Bioservices, Inc. Common Stock position peaked at $22.8K in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.